Skip to main content
Log in

Age- and Gender-Specific Incidence of Hospitalisation for Digoxin Intoxication

  • Correspondence
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Aarnoudse ALHJ, Dieleman JP, Stricker BHC. Age-and gender-specific incidence of hospitalisation for digoxin intoxication. Drug Saf 2007; 30(5): 431–6

    Article  PubMed  CAS  Google Scholar 

  2. Schneeweiss S, Hasford J, Göttler M, et al. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 2002 Jul; 58(4): 285–91

    Article  PubMed  Google Scholar 

  3. Begaud B, Evreux JC, Jouglard J, et al. Imputation of the unexpected or toxic effects of drugs: actualization of the method used in France [in French]. Therapie 1985 Mar–Apr; 40(2): 111–8

    PubMed  CAS  Google Scholar 

  4. Schmiedl S, Szymanski J, Rottenkolber M, et al. Analysis of hospital admissions associated with digitalis glycosides [in German]. Med Klin (Munich) 2007 Aug 15; 102(8): 603–11

    Article  Google Scholar 

  5. Warren JL. McBean AM, Hass SL, et al. Hospitalizations with adverse events caused by digitalis therapy among elderly Medicare beneficiaries. Arch Intern Med 1994 Jul 11; 154(13): 1482–7

    Article  PubMed  CAS  Google Scholar 

  6. Kernan WN, Castellsague J, Perlman GD, et al. Incidence of hospitalization for digitalis toxicity among elderly Americans. Am J Med 1994 May; 96(5): 426–31

    Article  PubMed  CAS  Google Scholar 

  7. Eschenhagen T. Kardiaka. In: Schwabe U, Paffrath D, editors. Arzneiverordnungs-Report 2005. Berlin, Heidelberg, New York: Springer, 2006: 686–90

    Google Scholar 

  8. Roever C, Ferrante J, Gonzalez EC, et al. Comparing the toxicity of digoxin and digitoxin in a geriatric population: should an old drug be rediscovered? South Med J 2000 Feb; 93(2): 199–202

    PubMed  CAS  Google Scholar 

  9. Hardman JG, Gilman AG, Limbird LE, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. 9th ed. New York: McGraw Hill, 1995

    Google Scholar 

  10. Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002 Oct 31; 347(18): 1403–11

    Article  PubMed  CAS  Google Scholar 

  11. Adams KF, Patterson JH, Gattis WA, et al. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial. J Am Coll Cardiol 2005 Aug 2; 46(3): 497–504

    Article  PubMed  CAS  Google Scholar 

  12. Glaeske G, Janhsen K. GEK-Arzneimittel-Report 2006. Auswertungsergebnisse der GEK-Arzneimitteldaten aus den Jahren 2004 and 2005. Sankt Augustin: Asgard, 2006: 274–5

    Google Scholar 

Download references

Acknowledgements

The study commented on in this letter was supported by BfArM (Federal Institute for Drugs and Medical Devices, Fo2.1-68502-201). The authors have no conflicts of interest that are directly relevant to the content of this letter.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmiedl, S., Szymanski, J., Rottenkolber, M. et al. Age- and Gender-Specific Incidence of Hospitalisation for Digoxin Intoxication. Drug-Safety 30, 1171–1173 (2007). https://doi.org/10.2165/00002018-200730120-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200730120-00009

Keywords

Navigation